E-LIB Suche - Ergebnisse für: Auranen, A.

1

37MO Dostarlimab plus chemotherapy in primary advanced or r..:

Powell, M.A. ; Auranen, A. ; Willmott, L.J....
ESMO Open. 9 (2024) - p. 103537 , 2024

Link: https://doi.org/10.1016/..

2

EE345 Lifetime Cost-Effectiveness of Hereditary Breast and ..:

Soini, E ; Asseburg, C ; Jalkanen, K...
Value in Health. 27 (2024) 6 - p. S120-S121 , 2024

Link: https://doi.org/10.1016/..

3

NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in ..:

Mirza, M.R. ; Tandaric, L. ; Henriksen, J.R....
Gynecologic Oncology. 188 (2024) - p. 103-110 , 2024

Link: https://doi.org/10.1016/..

4

EE64 Healthcare Resource Utilisation and Medical Costs Amon..:

Rauhamaa, H ; Herse, F ; Isomeri, O...
Value in Health. 25 (2022) 12 - p. S65 , 2022

Link: https://doi.org/10.1016/..

5

Clinical Value of 18 F-fluorodeoxyglucose Positron Emission..:

Hynninen, J. ; Laasik, M. ; Vallius, T....
Clinical Oncology. 30 (2018) 8 - p. 507-514 , 2018

Link: https://doi.org/10.1016/..

6

658: High-grade serous ovarian cancer subtyping identifies ..:

Huhtinen, K. ; Chen, P. ; Mikkonen, P....
European Journal of Cancer. 50 (2014) - p. S157 , 2014

Link: https://doi.org/10.1016/..

7

Electromagnetic hypersensitive Finns: Symptoms, perceived s..:

Hagström, M. ; Auranen, J. ; Ekman, R.
Pathophysiology. 20 (2013) 2 - p. 117-122 , 2013

Link: https://doi.org/10.1016/..

8

Reducing electromagnetic irradiation and fields alleviates ..:

Hagström, M. ; Auranen, J. ; Johansson, O..
Pathophysiology. 19 (2012) 2 - p. 81-87 , 2012

Link: https://doi.org/10.1016/..

9

P13.03: Comparison of two risk of malignancy indexes as a r..:

Auranen, A. ; Mäkinen, J. ; Palo, P....
Ultrasound in Obstetrics & Gynecology. 24 (2004) 3 - p. 343-343 , 2004

Link: https://doi.org/10.1002/..

10

Borderline Ovarian Tumors in Finland: Epidemiology and Fami..:

Auranen, A. ; Grenman, S. ; Makinen, J....
American Journal of Epidemiology. 144 (1996) 6 - p. 548-553 , 1996

Link: https://doi.org/10.1093/..

11

Sensitive circulating tumor DNA–based residual disease dete..:

Kallio, Heini ML ; Savolainen, Kalle ; Virtanen, Tuomo...
Life Science Alliance. 7 (2024) 6 - p. e202402658 , 2024

Link: https://doi.org/10.26508..

12

A national precision cancer medicine implementation initiat..:

Jalkanen, Katriina J. ; Alanne, Erika ; Iivanainen, Sanna...
Acta Oncologica. 63 (2024) - p. 395-397 , 2024

Link: https://doi.org/10.2340/..

13

Octupole correlations in the N = Z + 2 = 56 110Xe nucleus:

Illana, A. ; Pérez-Vidal, R.M. ; Stramaccioni, D....
Physics Letters B. 848 (2024) - p. 138371 , 2024

Link: https://doi.org/10.1016/..

14

Non-COVID-19 hospitalisation as a negative control outcome ..:

Poukka, Eero ; Auranen, Kari ; Baum, Ulrike
The Lancet Infectious Diseases. 24 (2024) 5 - p. e275 , 2024

Link: https://doi.org/10.1016/..

15

Deep Learning Test Platform for Maritime Applications: Deve..:

Kalliovaara, Juha ; Jokela, Tero ; Asadi, Mehdi...
Remote Sensing. 16 (2024) 9 - p. 1545 , 2024

Link: https://doi.org/10.3390/..